IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
Clinical trial NCT04086264 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04086264
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2027-02-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.